AstraZeneca and Daiichi Sankyo ’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...

AstraZeneca has received approval from the FDA for its BTK inhibitor, Calquence (acalabrutinib), for first-line use in MCL.

Trinasolar, a global leader in smart PV and energy storage, has partnered with Smart Commercial Solar to deliver an advanced solar panel installation for AstraZeneca's new major rooftop car park at ...

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Drugmaker AstraZeneca has teamed up with Indian digital ... The aim of the pilot is to scan and review more than 250,000 images generated at clinics in the Greater Manchester Cancer Alliance ...

Trapped-ion quantum computing leader IonQ (NYSE: IONQ) is emerging as a potential leader in the commercialization of quantum ...

Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot ...

Quantum computing has the potential to accelerate how companies and scientists process data, which could lead to more ...

Highlights:,ANGLE PLC, (OTC:ANPCY),specializes in cancer diagnostics with its Parsortix liquid biopsy system.,The company has ...

The AstraZeneca and Johnson & Johnson vaccines were linked to ... just assume it's going to bounce back without a concerted ...

One EU-funded project in the 1990s turned the medical world on its head by introducing 3D printing to healthcare. This led to ...